Form 4: Neumora Therapeutics Executive Transfers Shares to Family Trust

Daljit Singh Aurora, Chief Strategy Officer of Neumora Therapeutics, transferred 114,703 shares of common stock to the Aurora Family Trust on April 22, 2024.

Summary

• On April 22, 2024, Daljit Singh Aurora, the Chief Strategy Officer of Neumora Therapeutics, transferred 114,703 shares of common stock to the Aurora Family Trust.
• The transfer was made for no consideration.
• Members of Mr. Aurora's immediate family are the sole beneficiaries of the Aurora Family Trust.
• Following the transaction, Mr. Aurora directly owns 97,500 shares of Neumora Therapeutics common stock.
• The Aurora Family Trust indirectly holds 114,703 shares.

Sentiment

Score: 5

Explanation: Neutral. This is a standard regulatory filing related to an internal transfer of shares and doesn't inherently indicate positive or negative sentiment regarding the company's performance.

Industry Context

This is a routine disclosure of insider transactions and doesn't necessarily reflect a change in the company's outlook or performance. It is common for executives to manage their personal holdings for estate planning or tax purposes.

Related Party Transactions

• The transfer of shares to the Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries, constitutes a related party transaction.

Stakeholder Impact

• This transaction is unlikely to have a significant impact on stakeholders as it is a transfer of shares for estate planning purposes and does not involve a sale to the public market.

Key Dates